Abstract
The lipid-lowering, fibrinolytic, and anticoagulant effects of leucine-containing glyprolines, Pro-Gly-Pro-Leu and Leu-Pro-Gly-Pro, were studied in vitro in the blood of patients with disorders of lipid metabolism. The lipid-lowering impact of glyprolines and their ability to reduce the polymerization and to increase the depolymerization of fibrin in human blood were found. Possible mechanisms of lipolytic action of peptides by means of modulation of the lipid-dependent phospholipase A2 were proposed.
Similar content being viewed by others
References
Andreeva, L.A., Myasoedov, N.F., Lyapina, L.A., et al., Effect of the Pro-Gly-Pro peptide on hemostasis and lipid metabolism in rats with hypercholesterolemia, Dok. Biol. Sci, 2013, vol. 453, pp. 333–335.
Cojocaru, E., Zamfir, C., Zamosteanu, N., et al., The effects of branched chain aminoacids on hdl-cholesterol in experimental animals subjected to dietary hypercholesterolemia, Rev. Med. Chir. Soc. Med. Nat. Iasi., 2012, vol. 116, no. 1, pp. 200–206.
Colley, K.J., Wolfert, R.L., and Cobble, M., Lipoprotein-associated phospholipase A2 in atherosclerosis and its suitability for use as a biomarker of risk for cardiovascular disease, Ateroskleroz Dislipidemii, 2011, no. 3, pp. 1–4.
Gerber, Y., Dunlay, S.M., Jaffe, A.S., et al., Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community, Atherosclerosis, 2009, vol. 203, no. 2, pp. 593–598.
Kudrjashov, B.A. and Lyapina, L.A., Nonenzymatic fibrinolysis and its role in the organism, in Thrombosis and Thrombolysis, Chazov, E.I. and Smirnov, V.N., Eds., New York: Consultants Bureau, 1986, pp. 33–65.
Luc, G., Bard, J.M., Ferriéres, J., et al., Value of HDL cholesterol, apo A∼I, lipoprotein A-1 and lipoprotein A-I/A-II in prediction of coronary heart disease, Atheriosclerosis Thromb. Vasc. Biol., 2002, vol. 22, pp. 11–55.
Lyapina, L.A., Pastorova, V.E., and Obergan, T.Yu., Functional state of the anticoagulation system after the administration of complexes formed by natural heparin and the regulatory peptides: Pro-Gly, Pro-Gly-Pro, Semax and tuftsin, Neurochem. J., 2008, vol. 2, nos. 1–2, pp. 17–22.
Lyapina, L.A., Grigor’eva, M.E., Obergan, T.Yu., and Shubina, T.A., Teoreticheskie i prakticheskie voprosy izucheniya funktsional’nogo sostoyaniya protivosvertyvayushchei sistemy krovi (Theoretical and Practical Aspects of Studying the Functional State of the Blood Anticoagulation System), Moscow: Advansed Solyushnz, 2012.
Maksyutkina, L.N., Tanashyan, M.M., Lagoda, O.V., et al., Cerebrovascular diseases and carotid atherosclerosis: biomarkers of inflammation and coagulation, Klin. Nevrol., 2013, no. 3, pp. 16–23.
Obergan, T.Yu., Grigor’eva, M.E., Shubina, T.A., et al., Involvement of peptide PGPL in the restoration of the blood anticoagulative function and insular system of the body during the development of stable hyperglycemia in rats, Vopr. Biol. Med. Farmats. Khim., 2013, no. 4, pp. 38–42.
Shcherbak, I.G., Subbotina, T.F., Faenkova, V.P., et al., Turbidimetric analysis of fibrin polymerization in blood plasma, Vopr. Med. Khim., 2001, no. 1, pp. 43–47.
Suslina, Z.A., Tanashyan, M.M., and Ionova, V.G., Ishemicheskii insul’t: krov’, sosudistaya stenka, antitromboticheskaya terapiya (Ischemic Stroke: Blood, Vascular Wall, and Antithrombotic Therapy), Moscow: Med. Kniga, 2005.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.A. Shabalina, L.A. Lyapina, D.L. Rochev, M.V. Kostyreva, M.M. Tanashyan, Z.A. Suslina, 2015, published in Izvestiya Akademii Nauk, Seriya Biologicheskaya, 2015, No. 1, pp. 85–89.
Rights and permissions
About this article
Cite this article
Shabalina, A.A., Lyapina, L.A., Rochev, D.L. et al. In vitro lipid-lowering and fibrinolytic effects of regulatory leucine-containing glyprolines in human blood. Biol Bull Russ Acad Sci 42, 74–77 (2015). https://doi.org/10.1134/S1062359015010112
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1062359015010112